Phase 4 Hypertension Trial, Recruiting NCT05421767 Sponsor: National Taiwan University Hospital Condition: Hypertension
Back to Hypertension

Phase 4 Hypertension Trial, Recruiting

NCT05421767
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have high blood pressure, with a 24-hour blood pressure monitor reading above 130/80 mmHg
  • People aged between 20 and 80 years old
  • People whose kidneys are filtering at a sufficient level (a kidney function score above 45, as measured by a standard blood test)

Who may not be able to join:

  • People whose kidney arteries are too small or too short to work with the procedure, as shown on a specialised scan (confirm with trial site)
  • People who have high blood pressure caused by an untreated underlying medical condition, such as a hormone-producing tumour, an overactive adrenal gland disorder, or a significant narrowing of the kidney arteries (more than 50% blocked)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Registry
ClinicalTrials.gov
Start date
24 June 2022
Est. completion
31 December 2025

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

arterial blood pressure response

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov